Cameron Rokhsar, MD
Dermatology · New York, NYNPI 1801862271
Payments from drug & device makers
Across 151 payments — averaging $88.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Dermira, Inc.$2K
- Merz North America, Inc.$1K
- Galderma Laboratories, L.p.$603
- Dermavant Sciences, Inc.$369
- Sun Pharmaceutical Industries Inc.$351
- plus $1K from 17 others
What the payments were for
- Consulting fees$4,06631%
- Speaking & faculty fees$2,15016%
- Travel & lodging$9827%
- Food & beverage$6,00645%
- Education$1121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $7,361 |
| Dermira, Inc. | 6 | $2,283 |
| Merz North America, Inc. | 13 | $1,034 |
| Galderma Laboratories, L.p. | 16 | $603 |
| Dermavant Sciences, Inc. | 11 | $369 |
| Sun Pharmaceutical Industries Inc. | 12 | $351 |
| Regeneron Healthcare Solutions, Inc. | 7 | $316 |
| Sanofi | 8 | $222 |
| Amgen | 5 | $134 |
| Pfizer | 4 | $98 |
| Bristol Myers Squibb | 4 | $89 |
| Solta Medical, A Division Of Bausch Health US, LLC | 3 | $79 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Incyte Corporation | 3 | $66 |
| Arcutis Biotherapeutics, Inc. | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Journey Medical Corporation | 2 | $33 |
| Mayne Pharma Commercial LLC | 1 | $29 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Acelrx Pharmaceuticals, Inc. | 1 | $19 |
| Strata Skin Sciences, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,316 in reported general payments places this provider in the 75th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 66 | $4,699 |
| Clindamycin Phosphate | 19 | $576 |
| Cefadroxil | 86 | $324 |
| Econazole Nitrate | 13 | $295 |
| ValacyclovirValacyclovir Hcl | 18 | $291 |
| Mupirocin | 17 | $137 |
| Hydrocortisone | 13 | $124 |
| Clindamycin Hcl | 18 | $50 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Emma GuttmanNew York$35.3M
- Saakshi KhattriNew York$15.4M
- James KruegerNew York$6.3M
- Michael CameronNew York$5.8M
- Mark LebwohlNew York$5.8M
- Andrew AlexisNew York$5.7M
- Neil SadickNew York$4.2M
- Orit MarkowitzNew York$3.7M
- Alexandra GolantNew York$3.6M
- George HanNew York$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.